Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. Keeping that in mind, here are three stocks where Wall Street may be overlooking some important risks and some alternatives with better fundamentals.
Mission Produce (AVO)
Consensus Price Target: $17 (41.1% implied return)
Founded in 1983 in California, Mission Produce (NASDAQ: AVO) grows, packages, and distributes avocados.
Why Are We Out on AVO?
- Subscale operations are evident in its revenue base of $1.39 billion, meaning it has fewer distribution channels than its larger rivals
- Estimated sales decline of 15% for the next 12 months implies a challenging demand environment
- Commoditized products, bad unit economics, and high competition are reflected in its low gross margin of 10.9%
At $12.05 per share, Mission Produce trades at 15.4x forward EV-to-EBITDA. Dive into our free research report to see why there are better opportunities than AVO.
Penumbra (PEN)
Consensus Price Target: $318.63 (30.4% implied return)
Founded in 2004 to address challenging medical conditions with significant unmet needs, Penumbra (NYSE: PEN) develops and manufactures innovative medical devices for treating vascular diseases and providing immersive healthcare rehabilitation solutions.
Why Are We Hesitant About PEN?
- Modest revenue base of $1.24 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Poor free cash flow margin of 3% for the last five years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
- Negative returns on capital show management lost money while trying to expand the business
Penumbra is trading at $244.39 per share, or 61x forward P/E. Read our free research report to see why you should think twice about including PEN in your portfolio.
Root (ROOT)
Consensus Price Target: $149.80 (21.5% implied return)
Pioneering a data-driven approach that rewards good driving habits, Root (NASDAQ: ROOT) is a technology-driven auto insurance company that uses mobile apps to acquire customers and data science to price policies based on individual driving behavior.
Why Are We Cautious About ROOT?
- Annual book value per share declines of 162% for the past five years show its capital management struggled during this cycle
- Negative return on equity shows that some of its growth strategies have backfired
Root’s stock price of $123.30 implies a valuation ratio of 4.9x forward P/B. Check out our free in-depth research report to learn more about why ROOT doesn’t pass our bar.
Stocks We Like More
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
